Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin
Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin
复制标题
DOI:
10.1002/cbdv.200590111
复制
发表时间:
2005-01-01
影响因子:
2.9
通讯作者:
Pérez, JM
中科院分区:
文献类型:
--
作者:
Nguewa, PA;Fuertes, MA;Pérez, JM
We have determined the cytotoxic properties of pentamidine isethionate (2) towards the promastigotes of the protozoan parasite Leishmania infantum. The leishmanicidal activity of 2 was 60 times higher after 72 It of incubation than that of cisplatin (4). The pentamidine salt 2 induced a higher amount of programmed cell death (PCD) than cisplatin, which is associated with inhibition of DNA synthesis and cell-cycle arrest in the G2/M phase. Circular dichroism (CD) data indicate that binding of 2 to calf-thymus DNA (CT-DNA) induces conformational changes in the DNA double helix, consistent with a B -> A transition. Moreover, the interaction of 2 with ubiquitin led to a 6% increase in the P-sheet content of the protein as observed by CD spectroscopy. Fluorescence-spectroscopy studies agreed with the CD data, showing that the pentamidine portion of 2 induces a significant decrease in the fluorescence of the Ub residues Phe(4) and Phe(45) located on the beta-cluster of the molecule, but not of Tyr(59) on the alpha-cluster. These data indicate that pentamidine specifically modifies the beta-cluster, i.e., the 'basic face' of ubiquitin. Our results suggest that the biochemical mechanism of action of pentamidine may be a consequence of its dual binding to DNA and proteins.